BACKGROUND—Since its discovery in 1980, human T-cell lymphotropic virus type-1 (HTLV-
1) has been associated with a number of neurological diseases. The distribution of HTLV-1 …

The human T-cell lymphotropic virus type 1 (HTLV-1) is a retrovirus that infects about 20
million people worldwide and causes immune--mediated diseases of the nervous system …

HTLV-1 is a significant global health problem but remains largely confined to endemic areas
and risk groups. However, increasing migration may mean that the virus will be encountered …

Human T-cell lymphotropic virus type 1 (HTLV-1) is a retrovirus that infects about 20 million
people worldwide and causes immune-mediated diseases of the nervous system. The …

The 30th workshop of the HTLV European Research Network (HERN) was held in Madrid
on September 15–16, 2023. Over fifty researchers from Europe and America convened for a …

The human T cell lymphotropic virus type 1 (HTLV-1) is a retrovirus that infects 10–20 million
persons around the world. Initially associated with the hematological malignancy adult T cell …

A 53-year-old woman developed subacute onset of upper limb weakness, sensory loss and
cerebellar dysfunction. She was known to have human T-lymphotropic virus type 1 (HTLV-1) …

Human T-cell leukemia virus type 1 (HTLV-1) was the first human retrovirus discovered
when it was linked to an unusual T-cell lymphoma in 1980. It was later linked to a number of …

BACKGROUND: Human T-lymphotropic virus type 1 (HTLV-1) is known to cause HTLV-
associated myelopathy (HAM)/tropical spastic paraparesis and adult T cell leukemia. A …

Background The natural history of HTLV-1-associated myelopathy (HAM) has been mainly
described in HTLV-1 endemic countries such as Japan, Brazil and Martinique. Objectives …